Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Tan Sheet

Executive Summary

Bristol-Myers Squibb: Mead Johnson Enfamil infant formula sales fell 12% to $186 mil. in the first quarter, although nutritional division's performance for Q1 is "on plan," BMS asserts in April 25 earnings announcement. Total nutritional sales fell 8% to $463 mil. during the quarter, with international revenue up 8% and U.S. sales declining 18%. BMS division began rolling out DHA/ARA-fortified Enfamil LIPIL during the quarter. Worldwide consumer medicine sales dropped 16% to $96 mil. Total consolidated revenue, excluding nonrecurring items, fell 7% to $4.34 bil., with net earnings from continuing operations, excluding nonrecurring items, falling 30% to $875 mil...

You may also be interested in...



Bausch & Lomb OcuVite Line Extension Used In Natl. Eye Institute Study

Promotions for Bausch & Lomb's new Ocuvite PreserVision containing vitamins C and E, beta carotene, zinc and copper likely will stress the product's clinically proven eye health benefits.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS093954

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel